Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Tisagenlecleucel for the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Interim Report of the European Post-Authorisation Safety Study Conducted By EBMT

Blood (2024) 144 (Supplement 1): 607.

https://doi.org/10.1182/blood-2024-200367

Published: 2024

Journal Articles

Eltrombopag Added to Standard Immunosuppressive Treatment Improves Long-Term Outcomes As Front-Line Therapy for Severe Aplastic Anemia: Final 2-Year Analysis of EBMT-Saawp Race Study

Antonio M Risitano, Simona Iacobelli, Austin G. Kulasekararaj, Marleen Van Os, Sophie Terwel, Morag Griffin, Constantijn J.M. Halkes, Christian Recher, Fiorenza Barraco, Edouard Forcade, Carlos Vallejo, Beatrice Drexler, Jean-Baptiste Méar, Alexander Smith, Emanuele Angelucci, Reinier Raymakers, Marco R De Groot, Etienne Daguindau, Erfan Nur, Wilma Barcellini, Nigel H. Russell, Louis Terriou, Anna Paola Iori, Walter Barberi, Anna Sureda Balari, Isabel Sanchez-Ortega, Blanca Xicoy, Isidro Jarque Ramos, Jamie Cavenagh, Flore Sicre De Fontbrune, Camilla Frieri, Talha Munir, Jennifer Tjon, Suzanne Tavitian, Aline Praire, Laurence Clement, Florence Rabian, Luana Marano, Anita Hill, Elena Palmisani, Petra Muus, Serena Marotta, Fabiana Cacace, Marica Laurino, Jakob Passweg, Sr., Judith Marsh, Gerard Socie, Ghulam Mufti, Carlo Dufour, Regis Peffault De Latour

Blood (2024) 144 (Supplement 1): 302.

https://doi.org/10.1182/blood-2024-194699

Published: 2024

Journal Articles

Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee

Francesco Onida, Nico Gagelmann, Yves Chalandon, Guido Kobbe, Marie Robin, Argiris Symeonidis, Theo de Witte, Raphael Itzykson, Madlen Jentzsch, Uwe Platzbecker, Valeria Santini, Guillermo Sanz, Christof Scheid, Eric Solary, Peter Valent, Raffaela Greco, Isabel Sanchez-Ortega, Ibrahim Yakoub-Agha, Lisa Pleyer

Blood (2024) 143 (22): 2227–2244.

https://doi.org/10.1182/blood.2023023476

Published: 2024

Includes: Supplemental data

Journal Articles

Help for Ukrainian Hematology Patients (HUP) - a Global Initiative Supporting the Establishment of Hematology Centers and Hematopoietic Cell Transplantation Programs in a Time of War

Blood (2023) 142 (Supplement 1): 264.

https://doi.org/10.1182/blood-2023-185883

Published: 2023

Journal Articles

Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

Blood (2023) 142 (10): 865–877.

https://doi.org/10.1182/blood.2023020578

Published: 2023

Includes: Supplemental data

Journal Articles

Handling of Allogeneic HPC Grafts in European Transplant Centers during the COVID-19 Pandemic - a Survey from the Infectious Diseases and Cellular Therapy & Immunobiology Working Parties of the EBMT

Nina Worel, Per T Ljungman, Isabel Sánchez-Ortega, Jorinde D Hoogenboom, Nina S Knelange, Inge CM Verheggen, Dirk-Jan Eikema, Annalisa Ruggeri, Jurgen Kuball, Diana Averbuch, Rafael De La Camara, Christian Chabannon

Blood (2022) 140 (Supplement 1): 10439–10440.

https://doi.org/10.1182/blood-2022-165383

Published: 2022

Journal Articles

Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

Blood (2019) 134 (Supplement_1): 289.

https://doi.org/10.1182/blood-2019-128682

Published: 2019

Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime

Blood (2019) 134 (Supplement_1): 3325.

https://doi.org/10.1182/blood-2019-126507

Published: 2019

Journal Articles

A High Dose of Naïve CD8 + T-Cells Increases the Incidence of Graft-Versus-Host Disease (GvHD) after Donor Lymphocyte Infusions (DLIs) from HLA Identical Sibling Donors

Guillermo Ortí, Carlos Palacio, Irene García-Cadenas, Isabel Sánchez-Ortega, María-José Jimenez, MD, Carmen Azqueta, Guillermo Villacampa, Christelle M Ferra, Rocio Parody, Rodrigo Martino, Francesc Bosch, MD PhD, David Valcarcel, Sergio Querol

Blood (2019) 134 (Supplement_1): 3292.

https://doi.org/10.1182/blood-2019-124358

Published: 2019

Journal Articles

Therapy for Acute Myeloid Leukemia (AML) Adjusted to Genetic Data and Minimal Residual Disease: Results of the AML12 Trial of the Spanish Cetlam Group in Adults up to the Age of 70 Years

Blood (2017) 130 (Supplement 1): 567.

https://doi.org/10.1182/blood.V130.Suppl_1.567.567

Published: 2017

Journal Articles

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study

Blood (2017) 130 (Supplement 1): 1983.

https://doi.org/10.1182/blood.V130.Suppl_1.1983.1983

Published: 2017

Journal Articles

Prognostic VALUE of EARLY Drop in the Platelet Counts in Patients with VERY Low, Low and Intermediate Risk IPSS-R Myelodysplastic Syndromes. Results from a Single Center Analysis

Helena Pomares, Isabel Sánchez-Ortega, MD PhD, Javier Grau, MD PhD, Esther Alonso, Maite Encuentra, Anna Sureda, Montserrat Arnan Sangerman

Blood (2017) 130 (Supplement 1): 2968.

https://doi.org/10.1182/blood.V130.Suppl_1.2968.2968

Published: 2017

Journal Articles

Improving Risk Stratification of Patients with Myelodysplastic Syndromes By the Integration of Red Blood Cell Transfusion Dependency into the Revised International Prognostic Scoring System

Montserrat Arnan, Helena Pomares, Isabel Sánchez-Ortega, MD PhD, Ester Alonso, MD, Maria Condom, Maite Encuentra, Javier Grau, Anna Sureda, MD PhD

Blood (2016) 128 (22): 3178.

https://doi.org/10.1182/blood.V128.22.3178.3178

Published: 2016

Journal Articles

Non-Cryopreserved Autologous Hematopoietic Transplantation Has Less Short Term Complications, Faster Engraftment and Similar Transplant Outcomes Than Cryopreserved Modality in Multiple Myeloma and Lymphoma Patients. a Comparative Analysis of Two Centers

Mauricio Sarmiento, MD, Rocio Parody, MD PhD, Queralt Salas, MD, Nicole Beffermann, MD, Veronica Jara, RN, Pablo A Bertin, MD, Isabel Sánchez-Ortega, MD PhD, Pablo Ramirez, MD, Mauricio Ocqueteau, MD, Beatriz Patiño, NG, Anna Sureda, MD PhD

Blood (2016) 128 (22): 2261.

https://doi.org/10.1182/blood.V128.22.2261.2261

Published: 2016

Journal Articles

Autologous Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

Blood (2016) 128 (22): 678.

https://doi.org/10.1182/blood.V128.22.678.678

Published: 2016

Journal Articles

Donor Lymphocyte Infusions for Haematological Malignancy Relapse

Guillermo Orti, MD, Irene García-Cadenas, MD, Isabel Sánchez-Ortega, MD PhD, Mª Jose Jimenez, MD, Laura Alonso, MD, Carmen Azqueta, PhD, Cristina Diaz de Heredia, MD, Cristelle Ferra, MD, Rocio Parody, MD PhD, Jorge Sierra, MD PhD, Sergio Querol, MD PhD, David Valcarcel, MD PhD

Blood (2016) 128 (22): 5775.

https://doi.org/10.1182/blood.V128.22.5775.5775

Published: 2016

Journal Articles

Allogeneic Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

Blood (2016) 128 (22): 681.

https://doi.org/10.1182/blood.V128.22.681.681

Published: 2016

Journal Articles

Invasive Fungal Infections in Patients with High-Risk MDS and AML Treated with Azacitidine

Helena Pomares, MD, Montserrat Arnan, MD PhD, Isabel Sánchez-Ortega, MD PhD, Anna Sureda, MD PhD, Rafael F. Duarte, MD PhD

Blood (2015) 126 (23): 5251.

https://doi.org/10.1182/blood.V126.23.5251.5251

Published: 2015

Journal Articles

Validation of the Low Risk Prognostic Scoring System (LR-PSS) in Patients with VERY Low, Low and Intermediate Risk IPSS-R Myelodysplastic Syndrome. Results from a Single Center

Helena Pomares, MD, Isabel Sánchez-Ortega, MD PhD, Esther Alonso, MD, Javier Grau, MD, Rafael F. Duarte, MD PhD, Anna Sureda, MD PhD, Montserrat Arnan, MD PhD

Blood (2015) 126 (23): 2902.

https://doi.org/10.1182/blood.V126.23.2902.2902

Published: 2015

Journal Articles

Allogeneic Transplantation with CCR5 Δ32/Δ32 Cord Blood Hematopoietic Cells in a HIV-Infected Patient

Rafael F. Duarte, MD PhD, María Salgado, PhD, Isabel Sánchez-Ortega, MD PhD, Montserrat Arnan, MD PhD, Carmen Canals, MD PhD, Eva Domingo, MD, Alberto Fernández de Sevilla, MD PhD, Xavier García-Pont, MD, Eva González-Barca, MD PhD, Sara Morón-López, PhD, Nuria Nogues, MD, Beatriz Patiño, RN, Maria Carmen Puertas, PhD, Bonaventura Clotet, MD PhD, Lawrence D. Petz, MD, Sergio Querol, MD PhD, Javier Martinez-Picado, PhD

Blood (2014) 124 (21): 1261.

https://doi.org/10.1182/blood.V124.21.1261.1261

Published: 2014

NARROW

Tisagenlecleucel for the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: An Interim Report of the European Post-Authorisation Safety Study Conducted By EBMT

Eltrombopag Added to Standard Immunosuppressive Treatment Improves Long-Term Outcomes As Front-Line Therapy for Severe Aplastic Anemia: Final 2-Year Analysis of EBMT-Saawp Race Study

Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee

Help for Ukrainian Hematology Patients (HUP) - a Global Initiative Supporting the Establishment of Hematology Centers and Hematopoietic Cell Transplantation Programs in a Time of War

Immune effector cell–associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

Handling of Allogeneic HPC Grafts in European Transplant Centers during the COVID-19 Pandemic - a Survey from the Infectious Diseases and Cellular Therapy & Immunobiology Working Parties of the EBMT

Final Results of the AML12 Trial of the Spanish Cetlam Group in Adults with Acute Myeloid Leukemia (AML) up to the Age of 70 Years: Risk Adapted Post-Remission Allocation Based on Genetic Data and Minimal Residual Disease

Allogeneic Hematopoietic Stem Cell Transplantation for T Cell Lymphomas: Improved Results Overtime

A High Dose of Naïve CD8 + T-Cells Increases the Incidence of Graft-Versus-Host Disease (GvHD) after Donor Lymphocyte Infusions (DLIs) from HLA Identical Sibling Donors

Therapy for Acute Myeloid Leukemia (AML) Adjusted to Genetic Data and Minimal Residual Disease: Results of the AML12 Trial of the Spanish Cetlam Group in Adults up to the Age of 70 Years

Ruxolitinib in Refractory Acute and Chronic Graft-Versus-Host Disease: A Multi-Center Survey Study

Prognostic VALUE of EARLY Drop in the Platelet Counts in Patients with VERY Low, Low and Intermediate Risk IPSS-R Myelodysplastic Syndromes. Results from a Single Center Analysis

Improving Risk Stratification of Patients with Myelodysplastic Syndromes By the Integration of Red Blood Cell Transfusion Dependency into the Revised International Prognostic Scoring System

Non-Cryopreserved Autologous Hematopoietic Transplantation Has Less Short Term Complications, Faster Engraftment and Similar Transplant Outcomes Than Cryopreserved Modality in Multiple Myeloma and Lymphoma Patients. a Comparative Analysis of Two Centers

Autologous Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

Donor Lymphocyte Infusions for Haematological Malignancy Relapse

Allogeneic Hematopoietic Cell Transplantation in Elderly Patients Aged 65 and Older: A Retrospective Analysis By the Complications and Quality of Life Working Party of the EBMT

Invasive Fungal Infections in Patients with High-Risk MDS and AML Treated with Azacitidine

Validation of the Low Risk Prognostic Scoring System (LR-PSS) in Patients with VERY Low, Low and Intermediate Risk IPSS-R Myelodysplastic Syndrome. Results from a Single Center

Allogeneic Transplantation with CCR5 Δ32/Δ32 Cord Blood Hematopoietic Cells in a HIV-Infected Patient

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only